On the whole, we provide the first evidence that that RAB27B inhibits proliferation and promotes apoptosis of leukemic cells via interacting with BDH2, revealing that the RAB27B can functionally act as a prognostic marker of AML and targeting RAB27B may be conducive to the management of AML. Here, BDH2 is linked to acute myeloid leukemia.